StonvexLoading…
StonvexStonvexStonvexCore line items from NGNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2018 2018-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $925.00K | $0.00 | $25.00M |
Operating Income | $-103.33M | $-82.61M | $-55.58M | $-32.62M |
Net Income | $-90.35M | $-75.14M | $-36.32M | $-31.59M |
EPS (Diluted) | $-4.24 | $-4.28 | $2.93 | Not available |
Total Assets | $288.60M | $335.73M | $222.57M | $77.62M |
Total Liabilities | $23.72M | $25.36M | $36.55M | $4.95M |
Cash & Equivalents | $103.84M | $136.59M | $148.21M | $76.93M |
Free Cash Flow OCF − CapEx | $-78.36M | $-71.41M | $-51.74M | $-31.63M |
Shares Outstanding | 15.49M | 14.85M | 12.82M | 23.54M |